Analysis of IL-6/gp130 family receptor expression reveals that in contrast to astroglia, microglia lack the oncostatin M receptor and functional responses to oncostatin M.
Level 5 - mechanism / opinion, no new human data
In vitro laboratory study in murine cells (bench research)
PubMed 25103368 · doi:10.1002/glia.22739
What was done
Researchers evaluated mRNA and protein expression of IL-6/gp130 family receptors (OSMR, IL-6R, LIFR, IL-11R) and downstream signaling pathway activation (STAT1, STAT3, NF-κB, iNOS, and nitrite production) in cultured murine astrocytes and microglia exposed to oncostatin M (OSM) and hyper-IL-6.
What was found
The abstract reports relative qualitative patterns without numerical figures: - Astrocytes expressed high OSMR mRNA and detectable OSMR protein, with lower levels of IL-6R, LIFR, and IL-11R mRNA, and undetectable IL-6R protein. OSM induced STAT1 and STAT3 phosphorylation in astrocytes. - Microglia had undetectable OSMR mRNA and protein, higher IL-6R mRNA, detectable IL-6R protein, and lower LIFR and IL-11R mRNA. OSM failed to activate STAT1 or STAT3 in microglia. - Both cell types responded to hyper-IL-6. - Neither cell type showed NF-κB activation, iNOS induction, or nitrite production in response to OSM.
Why it matters
The findings define a molecular mechanism for cellular specificity in neuroinflammatory signaling, demonstrating that OSM acts directly on astrocytes rather than microglia in the mouse CNS.
Limits
The study is restricted to in vitro murine cell cultures, which may not replicate in vivo microenvironments or translate directly to human glial physiology. No quantitative measurements, replicates, or sample sizes were reported in the abstract.
Cited by
- supports The brain expresses receptors for IL-6.